JP2023503380A5 - - Google Patents
Info
- Publication number
- JP2023503380A5 JP2023503380A5 JP2022532785A JP2022532785A JP2023503380A5 JP 2023503380 A5 JP2023503380 A5 JP 2023503380A5 JP 2022532785 A JP2022532785 A JP 2022532785A JP 2022532785 A JP2022532785 A JP 2022532785A JP 2023503380 A5 JP2023503380 A5 JP 2023503380A5
- Authority
- JP
- Japan
- Prior art keywords
- lys
- hyp
- dopa
- pro
- thr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2019/122391 | 2019-12-02 | ||
| CNPCT/CN2019/122391 | 2019-12-02 | ||
| PCT/CN2020/133436 WO2021110061A1 (en) | 2019-12-02 | 2020-12-02 | Peptides and their use in the treatment of inflammation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023503380A JP2023503380A (ja) | 2023-01-27 |
| JP2023503380A5 true JP2023503380A5 (cg-RX-API-DMAC7.html) | 2023-12-11 |
| JP7895852B2 JP7895852B2 (ja) | 2026-07-28 |
Family
ID=76221459
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022532756A Pending JP2023503374A (ja) | 2019-12-02 | 2020-12-02 | 新規なペプチドと多糖類とのコンジュゲート |
| JP2022532785A Active JP7895852B2 (ja) | 2019-12-02 | 2020-12-02 | ペプチド及び炎症の治療におけるそれらの使用 |
| JP2026005938A Pending JP2026067913A (ja) | 2019-12-02 | 2026-01-16 | 新規なペプチドと多糖類とのコンジュゲート |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022532756A Pending JP2023503374A (ja) | 2019-12-02 | 2020-12-02 | 新規なペプチドと多糖類とのコンジュゲート |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026005938A Pending JP2026067913A (ja) | 2019-12-02 | 2026-01-16 | 新規なペプチドと多糖類とのコンジュゲート |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20240218016A1 (cg-RX-API-DMAC7.html) |
| EP (2) | EP4069713A4 (cg-RX-API-DMAC7.html) |
| JP (3) | JP2023503374A (cg-RX-API-DMAC7.html) |
| KR (2) | KR20220117256A (cg-RX-API-DMAC7.html) |
| CN (2) | CN114929726A (cg-RX-API-DMAC7.html) |
| AU (2) | AU2020396818A1 (cg-RX-API-DMAC7.html) |
| CA (2) | CA3160127A1 (cg-RX-API-DMAC7.html) |
| TW (2) | TW202133882A (cg-RX-API-DMAC7.html) |
| WO (2) | WO2021110063A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4028409A4 (en) | 2019-09-14 | 2023-10-11 | EnliTISA (Shanghai) Pharmaceutical Co., Ltd. | NEW PEPTIDES |
| JP2026506026A (ja) * | 2023-02-13 | 2026-02-20 | エンリティザ(シャンハイ)ファーマシューティカル カンパニー リミテッド | 新規多機能オリゴペプチド |
| AU2024312518A1 (en) * | 2023-06-22 | 2026-01-22 | Enlitisa (Shanghai) Pharmaceutical Co., Ltd. | New multi-functional oligopeptides |
| WO2025195444A1 (en) | 2024-03-20 | 2025-09-25 | Enlitisa (Shanghai) Pharmaceutical Co., Ltd. | New use of peptides derived from vasoactive intestinal peptide |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH02500082A (ja) * | 1987-03-12 | 1990-01-18 | ジェネックス・コーポレーション | 遺伝子操作された生物による生物粘着物質前駆体タンパク質類似体の生産 |
| US5229490A (en) * | 1987-05-06 | 1993-07-20 | The Rockefeller University | Multiple antigen peptide system |
| US4908404A (en) * | 1988-08-22 | 1990-03-13 | Biopolymers, Inc. | Synthetic amino acid-and/or peptide-containing graft copolymers |
| US5616311A (en) * | 1991-01-15 | 1997-04-01 | Hemosphere, Inc. | Non-crosslinked protein particles for therapeutic and diagnostic use |
| EP0831793A4 (en) * | 1995-06-06 | 2000-11-15 | Hemosphere Inc | PROTEIN PARTICLES FOR THERAPEUTIC AND DIAGNOSTIC USE |
| WO2000015789A1 (en) * | 1998-09-09 | 2000-03-23 | United States Surgical Corporation | Recombinant bioadhesive protein analogs comprising hydroxyproline |
| US20030191291A1 (en) * | 2000-09-08 | 2003-10-09 | Kochendoerfer Gerd G. | Synthetic erythropoiesis stimulating proteins |
| CU23011A1 (es) * | 2000-11-03 | 2004-12-17 | Ct Ingenieria Genetica Biotech | Método de obtención de estructuras antigénicas quemétodo de obtención de estructuras antigénicas que potencian la reactividad cruzada específica y su potencian la reactividad cruzada específica y su uso en formulaciones uso en formulaciones |
| JP5133048B2 (ja) * | 2004-02-27 | 2013-01-30 | ノースウエスタン ユニバーシティ | 重合化合物及び関連した使用方法 |
| WO2007124593A1 (en) * | 2006-05-02 | 2007-11-08 | Universite Laval | Branched peptide amplification and uses thereof |
| WO2009001220A2 (en) * | 2007-06-26 | 2008-12-31 | Universitetet I Oslo | Functionalization of microscopy probe tips |
| US20130224269A1 (en) * | 2010-11-15 | 2013-08-29 | Avon Products, Inc. | Biofunctional Anchored Extended-Wear Cosmetics |
| JP6202669B2 (ja) * | 2013-04-26 | 2017-09-27 | 国立研究開発法人国立循環器病研究センター | ペプチド及びその複合体、組織修復用スキャフォールド及びその表面処理方法、並びに表面処理液又は処理液のセット |
| KR101677097B1 (ko) * | 2015-03-18 | 2016-11-18 | 포항공과대학교 산학협력단 | 내부 장기의 접합 및 누공, 천공 또는 문합부 누출 치료용 접착 실란트 |
| MX2017013196A (es) * | 2015-04-17 | 2018-06-19 | Symic Ip Llc | Bioconjugados y usos de los mismos. |
| KR102468524B1 (ko) * | 2015-07-20 | 2022-11-18 | 장인 벵트 아이. 사무엘손 인스티튜트 오브 라이프 사이언스 컴퍼니 리미티드 | 멜라닌과 관련된 질환의 치료 및 예방에서의 홍합 접착 단백질 제품의 용도 |
| BR112018000953A2 (pt) * | 2015-07-20 | 2018-09-11 | Bengt I. Samuelsson Institute Of Life Science Research | produto de proteína adesiva de mexilhão e aplicações do mesmo na supressão de inflamações de pele |
| WO2017028025A1 (zh) * | 2015-08-14 | 2017-02-23 | 江阴市本特塞缪森生命科学研究院有限公司 | 贻贝粘蛋白产品及其抑制粘膜炎症的应用 |
| WO2017088177A1 (zh) * | 2015-11-27 | 2017-06-01 | 江阴市本特塞缪森生命科学研究院有限公司 | 贻贝粘蛋白产品及其预防和抑制神经炎症的应用 |
| KR101807593B1 (ko) * | 2015-12-30 | 2017-12-11 | 포항공과대학교 산학협력단 | 흉터 최소화 상처 재생 촉진용 재조합 폴리펩타이드 및 이를 포함하는 생체 접착 소재 |
| AR110299A1 (es) * | 2016-12-02 | 2019-03-13 | Sanofi Sa | Conjugados que comprenden un agonista dual de glp-1 / glucagón, un conector y ácido hialurónico |
| CA3068818A1 (en) * | 2017-07-05 | 2019-01-10 | Jiangyin Mucocare Pharmaceutical Co., Ltd | Topical formulations comprising montelukast and combinations with mussel adhesive proteins |
| CN110139662B (zh) * | 2017-07-05 | 2022-03-18 | 江阴贝瑞森制药有限公司 | 肽的抗炎用途 |
| KR102010051B1 (ko) * | 2017-09-20 | 2019-08-12 | 주식회사 포스코 | 카테콜 치환된 음이온성 고분자로부터 형성된 코아세르베이트, 이를 포함하는 접착제 및 이의 제조방법 |
| KR102954778B1 (ko) * | 2018-03-09 | 2026-04-20 | 발리터 인코포레이티드 | 관절 염증의 지속적인 관절내 치료를 위한 다가 펩티드 컨쥬게이트 |
| MA52794A (fr) * | 2018-05-28 | 2021-04-14 | Jiangyin Usun Pharmaceutical Co Ltd | Nouvelle utilisation pharmaceutique |
| HUE062848T2 (hu) * | 2018-09-14 | 2023-12-28 | Enlitisa Shanghai Pharmaceutical Co Ltd | Montelukaszt és peptidek konjugátumai |
-
2020
- 2020-12-02 US US17/781,571 patent/US20240218016A1/en active Pending
- 2020-12-02 TW TW109142487A patent/TW202133882A/zh unknown
- 2020-12-02 JP JP2022532756A patent/JP2023503374A/ja active Pending
- 2020-12-02 JP JP2022532785A patent/JP7895852B2/ja active Active
- 2020-12-02 KR KR1020227022784A patent/KR20220117256A/ko active Pending
- 2020-12-02 EP EP20896452.8A patent/EP4069713A4/en active Pending
- 2020-12-02 US US17/781,543 patent/US20230113836A1/en active Pending
- 2020-12-02 WO PCT/CN2020/133438 patent/WO2021110063A1/en not_active Ceased
- 2020-12-02 EP EP20897392.5A patent/EP4069715A4/en active Pending
- 2020-12-02 CN CN202080083112.1A patent/CN114929726A/zh active Pending
- 2020-12-02 CN CN202080083154.5A patent/CN114929283A/zh active Pending
- 2020-12-02 AU AU2020396818A patent/AU2020396818A1/en active Pending
- 2020-12-02 KR KR1020227022746A patent/KR20220116468A/ko active Pending
- 2020-12-02 CA CA3160127A patent/CA3160127A1/en active Pending
- 2020-12-02 WO PCT/CN2020/133436 patent/WO2021110061A1/en not_active Ceased
- 2020-12-02 TW TW109142488A patent/TW202128729A/zh unknown
- 2020-12-02 CA CA3160167A patent/CA3160167A1/en active Pending
- 2020-12-02 AU AU2020396109A patent/AU2020396109A1/en active Pending
-
2026
- 2026-01-16 JP JP2026005938A patent/JP2026067913A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2575816B1 (en) | Combination therapy for skin disorders | |
| JP2022500437A5 (cg-RX-API-DMAC7.html) | ||
| TWI250163B (en) | Combretastatin A-4 phosphate prodrug mono-and di-organic amine salts, mono-and di-amino acid salts, and mono-and di-amino acid ester salts | |
| US12612430B2 (en) | Peptides | |
| TW201441186A (zh) | 用於治療纖維化之經取代之芳族化合物及相關方法 | |
| JP2024517738A5 (cg-RX-API-DMAC7.html) | ||
| EP2660247A2 (en) | High penetration prodrug compositions of peptides and peptide-related compounds | |
| IE903302A1 (en) | Topical preparation for treatment of aphthous ulcers and¹other lesions | |
| WO2021110061A1 (en) | Peptides and their use in the treatment of inflammation | |
| CA2706738A1 (en) | Treatment of mixed pathogen infections | |
| JP2025118775A5 (cg-RX-API-DMAC7.html) | ||
| WO2023169557A1 (zh) | 一种次黄碱衍化合物在制备治疗肺纤维化药物中的应用 | |
| CN120731082A (zh) | 新多功能寡肽 | |
| WO2003066572B1 (en) | Polyamine compounds and compositions for use in conjunction with cancer therapy | |
| JP2003522786A5 (cg-RX-API-DMAC7.html) | ||
| JP2803477B2 (ja) | ヘキサペプチド | |
| JP2004510775A5 (cg-RX-API-DMAC7.html) | ||
| JPH11505243A (ja) | Aii受容体アンタゴニストの新規な薬理学的使用 | |
| JP2001505544A (ja) | フルオシノニド含有経口組成物 | |
| JP2022543056A5 (cg-RX-API-DMAC7.html) | ||
| RU2021105972A (ru) | Новые конъюгаты монтелукаста и пептидов | |
| CN1700914A (zh) | 口腔等粘膜中的炎性疾病的预防或治疗剂 | |
| JP7836044B2 (ja) | 抗菌性ジペプチド化合物 | |
| JPH09502427A (ja) | オキシトシン拮抗薬活性を示すペプチド | |
| HK40081672A (en) | High penetration prodrug compositions of peptides and peptide related compounds |